BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 2173294)

  • 21. Vascular rejection of renal allografts is linked to CMV IgG, positive organ donor.
    Tenschert W; Dittmer R; Harfmann P; Cremaschi L; Meyer-Moldenhauer WH; Arndt R; Klosterhalfen H
    Transplant Proc; 1991 Oct; 23(5):2641-2. PubMed ID: 1656565
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cytomegalovirus diseases following allogenic kidney transplantation].
    Tenschert W; Huland H
    Med Klin (Munich); 1992 Oct; 87 Suppl 1():43-8. PubMed ID: 1334221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Importance of screening for antibodies to cytomegalovirus in organ transplantation].
    Milbradt H; Flik J; Stangel W; Heigel R
    Beitr Infusionsther; 1990; 26():33-6. PubMed ID: 1703866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoglobulin M to cytomegalovirus in primary and reactivation infections in renal transplant recipients.
    Chou S; Kim DY; Scott KM; Sewell DL
    J Clin Microbiol; 1987 Jan; 25(1):52-5. PubMed ID: 3025251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [CMV antibody determination with two enzyme immunoassays in each case].
    Albert S; Sibrowski W; Kühnl P; Knödler B; Seidl S; Böhm BO; Doerr HW
    Beitr Infusionsther; 1990; 26():40-2. PubMed ID: 1703884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
    Ahsan N; Holman MJ; Yang HC
    Clin Transplant; 1997 Dec; 11(6):633-9. PubMed ID: 9408699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a radioimmunoassay for IgM-class antibodies against cytomegalovirus.
    Kangro HO
    Br J Exp Pathol; 1980 Oct; 61(5):512-20. PubMed ID: 6255978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
    Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
    Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Persistence of antibodies of the IgG class against cytomegaloviruses in blood donors].
    Eichler C; Kaden J; Blauärmel O; Zimmermann G; Adamczyk G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(4):560-9. PubMed ID: 2446998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The diagnostic problems in cytomegalovirus infection in patients with a transplanted kidney].
    Obujh NB; Martynova VN; Son'kina AA
    Ter Arkh; 1991; 63(6):79-81. PubMed ID: 1658959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CMV-specific polymeric and monomeric IgA antibodies in serum of renal transplant patients.
    Merlino C; Angeretti A; Segoloni GP; Giacchino F; Rossetti M; Negro Ponzi A
    Panminerva Med; 1991; 33(4):173-9. PubMed ID: 1666907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative measurement of cytomegalovirus-specific IgG and IgM antibodies in relation to cytomegalovirus antigenaemia and disease activity in kidney recipients with an active cytomegalovirus infection.
    Van der Giessen M; van den Berg AP; van der Bij W; Postma S; van Son WJ; The TH
    Clin Exp Immunol; 1990 Apr; 80(1):56-61. PubMed ID: 2157567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of anti-cytomegalovirus IgM in kidney graft recipients.
    Tardy JC; Pouteil-Noble C; Touraine JL; Aymard M
    Transplant Proc; 1987 Oct; 19(5):4066-7. PubMed ID: 2823432
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cytomegalovirus infections in dialysis patients].
    Sperschneider H; Färber I; Stein G; Schneider S
    Z Urol Nephrol; 1984 Apr; 77(4):231-5. PubMed ID: 6331026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples.
    Dangel V; Bäder U; Enders G
    J Clin Virol; 2006 Mar; 35(3):303-9. PubMed ID: 16298547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytomegalovirus disease in renal transplant recipients: an Iranian experience.
    Nemati E; Taheri S; Pourfarziani V; Einollahi B
    Exp Clin Transplant; 2008 Jun; 6(2):132-6. PubMed ID: 18816240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Frequency of infection with cytomegaloviruses (CMV) following kidney transplantation and initial experiences with CMV gamma globulin prevention].
    Kaden J; Scholz D; Eichler C; May G
    Immun Infekt; 1985 Nov; 13(6):290-5. PubMed ID: 3000922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytomegalovirus antibody avidity in allogeneic bone marrow recipients: evidence for primary or secondary humoral responses depending on donor immune status.
    Lutz E; Ward KN; Szydlo R; Goldman JM
    J Med Virol; 1996 May; 49(1):61-5. PubMed ID: 8732861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cytomegalovirus infection in patients after kidney transplantation].
    Nouza M; Korcáková L
    Cas Lek Cesk; 1996 Jul; 135(14):454-7. PubMed ID: 8925546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid diagnosis of cytomegalovirus infection in renal transplant recipients.
    Lautenschlager I; Suni J; Ahonen J; Grönhagen-Riska C; Räisänen S; Tukiainen P
    Transplant Proc; 1988 Jun; 20(3):408-9. PubMed ID: 2837851
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.